Serveur d'exploration sur la COVID en France - Exploration (Accueil)

Index « Titre (en) » - entrée « antiviral »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
antithrombotic < antiviral < anxiety  Facettes :

List of bibliographic references indexed by antiviral

Number of relevant bibliographic references: 13.
Ident.Authors (with country if any)Title
000358 (2020) Antonio Gonçalves [France] ; Julie Bertrand [France] ; Ruian Ke [États-Unis] ; Emmanuelle Comets [France] ; Xavier De Lamballerie [France] ; Denis Malvy [France] ; Andrés Pizzorno [France] ; Olivier Terrier [France] ; Manuel Rosa Calatrava [France] ; France Mentré [France] ; Patrick Smith [États-Unis] ; Alan S. Perelson [États-Unis] ; Jérémie Guedj [France]Timing of Antiviral Treatment Initiation is Critical to Reduce SARS-CoV-2 Viral Load.
000535 (2020) Jacques Fantini [France] ; Henri Chahinian [France] ; Nouara Yahi [France]Synergistic antiviral effect of hydroxychloroquine and azithromycin in combination against SARS-CoV-2: What molecular dynamics studies of virus-host interactions reveal.
000536 (2020) Jacques Fantini [France] ; Henri Chahinian [France] ; Nouara Yahi [France]Synergistic antiviral effect of hydroxychloroquine and azithromycin in combination against SARS-CoV-2: What molecular dynamics studies of virus-host interactions reveal.
000685 (2020) Mathieu E. Rebeaud [Suisse] ; Florian Zores [France]SARS-CoV-2 and the Use of Chloroquine as an Antiviral Treatment.
000820 (2020) Marc Montana [France] ; Vincent Montero [France] ; Omar Khoumeri [France] ; Patrice Vanelle [France]Quinoxaline Derivatives as Antiviral Agents: A Systematic Review.
000951 (2020) Markus Zeitlinger [Autriche] ; Birgit C P. Koch [Pays-Bas] ; Roger Bruggemann [Pays-Bas] ; Pieter De Cock [Belgique] ; Timothy Felton [Royaume-Uni] ; Maya Hites [Belgique] ; Jennifer Le [États-Unis] ; Sonia Luque [Espagne] ; Alasdair P. Macgowan [Royaume-Uni] ; Deborah J E. Marriott [Australie] ; Anouk E. Muller [Pays-Bas] ; Kristina Nadrah [Slovénie] ; David L. Paterson [Australie] ; Joseph F. Standing [Royaume-Uni] ; João P. Telles [Brésil] ; Michael Wölfl-Duchek [Autriche] ; Michael Thy [France] ; Jason A. Roberts [Australie, France]Pharmacokinetics/Pharmacodynamics of Antiviral Agents Used to Treat SARS-CoV-2 and Their Potential Interaction with Drugs and Other Supportive Measures: A Comprehensive Review by the PK/PD of Anti-Infectives Study Group of the European Society of Antimicrobial Agents.
000A53 (2020) J M Molina [France] ; C. Delaugerre [France] ; J. Le Goff [France] ; B. Mela-Lima [France] ; D. Ponscarme [France] ; L. Goldwirt [France] ; N. De Castro [France]No evidence of rapid antiviral clearance or clinical benefit with the combination of hydroxychloroquine and azithromycin in patients with severe COVID-19 infection.
000A60 (2020) Christian A. Devaux [France] ; Jean-Marc Rolain [France] ; Philippe Colson [France] ; Didier Raoult [France]New insights on the antiviral effects of chloroquine against coronavirus: what to expect for COVID-19?
000B08 (2020) Roberto Gomeni [France] ; Tianhong Xu [République populaire de Chine] ; Xuejuan Gao [République populaire de Chine] ; Françoise Bressolle-Gomeni [France]Model based approach for estimating the dosage regimen of indomethacin a potential antiviral treatment of patients infected with SARS CoV-2.
000D01 (2020) Andrés Pizzorno [France] ; Blandine Padey [France] ; Julia Dubois [France] ; Thomas Julien [France] ; Aurélien Traversier [France] ; Victoria Dulière [France] ; Pauline Brun [France] ; Bruno Lina [France] ; Manuel Rosa-Calatrava [France] ; Olivier Terrier [France]In vitro evaluation of antiviral activity of single and combined repurposable drugs against SARS-CoV-2.
000D94 (2020) Rachid Tahiri Joutei Hassani [France] ; Ahmed Bennis [Maroc]Hydroxychloroquine as antiviral prophylaxis for exposed caregivers to Covid-19: An urgent appraisal is needed.
000F27 (2020) Canan G. Nebigil [France] ; Christiane Moog [France] ; Stéphan Vagner [France] ; Nadia Benkirane-Jessel [France] ; Duncan R. Smith [Thaïlande] ; Laurent Désaubry [France]Flavaglines as natural products targeting eIF4A and prohibitins: From traditional Chinese medicine to antiviral activity against coronaviruses.
001695 (2020) Paul Gougis [France] ; Charlotte Fenioux [France] ; Christian Funck-Brentano [France] ; Marianne Veyri [France] ; Joseph Gligorov [France] ; Caroline Solas [France] ; Jean-Philippe Spano [France]Anticancer drugs and COVID-19 antiviral treatments in patients with cancer: What can we safely use?

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidFranceV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Title.i -k "antiviral" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Title.i  \
                -Sk "antiviral" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    CovidFranceV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    Title.i
   |clé=    antiviral
}}

Wicri

This area was generated with Dilib version V0.6.37.
Data generation: Tue Oct 6 23:31:36 2020. Site generation: Fri Feb 12 22:48:37 2021